NCT05189314 RFA of Benign Thyroid Nodules: Clinical Outcomes and Quality of Life Study
| NCT ID | NCT05189314 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Columbia University |
| Condition | Thyroid Nodules |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2019-08-30 |
| Primary Completion | 2027-08 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2019-08-30 with a primary completion date of 2027-08.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this observational research is to evaluate and compare clinical outcomes after treatment for symptomatic benign multinodular goiter (MNG) patients. This is a data collection study in which we ask participants to give access to information generated before and after treatment of their condition.
Eligibility Criteria
Inclusion Criteria: * Adult patients \>/=18 years old with benign thyroid nodules Exclusion Criteria: * cardiac arrhythmia * pregnancy
Contact & Investigator
Jennifer H Kuo, MD MS
PRINCIPAL INVESTIGATOR
Columbia University
Frequently Asked Questions
Who can join the NCT05189314 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Thyroid Nodules. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05189314 currently recruiting?
Yes, NCT05189314 is actively recruiting participants. Contact the research team at jhk2029@cumc.columbia.edu for enrollment information.
Where is the NCT05189314 trial being conducted?
This trial is being conducted at New York, United States.
Who is sponsoring the NCT05189314 clinical trial?
NCT05189314 is sponsored by Columbia University. The principal investigator is Jennifer H Kuo, MD MS at Columbia University. The trial plans to enroll 100 participants.